Anzeige
Meldung des Tages: SGS liefert den Ritterschlag: Weltklasse-Tests machen aus einem Explorer plötzlich ein Industrie-Asset

Insmed Aktie News

Aktie
WKN:  A1JJA3 ISIN:  US4576693075 US-Symbol:  INSM Branche:  Biotechnologie Land:  USA
156,32 $
-7,19 $
-4,40%
133,72 € 21.01.26
Depot/Watchlist
Marktkapitalisierung *
27,47 Mrd. €
Streubesitz
-
KGV
-28,49
neu: Nachhaltigkeits-Score
45 %
Index-Zuordnung
Nasdaq 100

Insmed News

23.04.25 - PR Newswire
Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025
Insmed to Host First-​Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 PR Newswire
25.03.25 - PR Newswire
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference PR Newswire
10.03.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
24.02.25 - PR Newswire
Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis PR ...
20.02.25 - PR Newswire
Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update
Insmed Reports Fourth-​Quarter and Full-Year 2024 Financial Results and Provides Business Update PR Newswire
10.02.25 - PR Newswire
Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025
Insmed to Host Fourth-​Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025 PR Newswire
07.02.25 - Börse-Global
Insmed Aktie: Positive Marktposition gesichert!
In einer bemerkenswerten Entwicklung haben mehrere hochrangige Führungskräfte des Biotech-​Unternehmens Insmed in der vergangenen Woche umfangreiche Aktienverkäufe ...
07.02.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
06.02.25 - PR Newswire
FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025
FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025 PR Newswire

Newssuche

Videos

newspaper
20.01.26 +5,33%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »